| scholarly article | Q13442814 |
| P2093 | author name string | Carlos E Rochitte | |
| José C Nicolau | |||
| Anis Rassi | |||
| Suzana A Silva | |||
| Hélio J Castello | |||
| Adriano Caixeta | |||
| Hans F R Dohmann | |||
| Remo H M Furtado | |||
| Edgard Quintella | |||
| Costantino R Costantini | |||
| Adrian P M Korman | |||
| Antonio C C de Carvalho | |||
| João B M C Moraes | |||
| Marco A Mattos | |||
| MiHeart/AMI Investigators | |||
| P2860 | cites work | Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction | Q22250889 |
| Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis | Q22306551 | ||
| Stem cell treatment for acute myocardial infarction | Q24186920 | ||
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. | Q26782024 | ||
| Current evidence base for use of the implantable cardioverter-defibrillator | Q27005963 | ||
| Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction | Q28208692 | ||
| Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
| Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial | Q29620043 | ||
| Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction | Q30824170 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial | Q31033745 | ||
| Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction | Q33273736 | ||
| Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial | Q34074673 | ||
| Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction | Q34187441 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial | Q34467911 | ||
| Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators | Q34539986 | ||
| Multicenter randomized trial of cell therapy in cardiopathies - MiHeart Study. | Q35613592 | ||
| A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial†. | Q35787443 | ||
| A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 | ||
| Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Ba | Q36765797 | ||
| Multicenter double blind trial of autologous bone marrow mononuclear cell transplantation through intracoronary injection post acute myocardium infarction - MiHeart/AMI study | Q36793619 | ||
| Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction: The PREDICTS Study | Q36861721 | ||
| Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? | Q38104209 | ||
| Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function | Q38452784 | ||
| Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy: Possible Modulating Effects of Paracrine Activities of Stem Cells | Q38620010 | ||
| Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials | Q39222871 | ||
| Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both | Q39669015 | ||
| Factors explaining the under-use of reperfusion therapy among ideal patients with ST-segment elevation myocardial infarction | Q40318237 | ||
| Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines | Q40783492 | ||
| Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial | Q43610373 | ||
| ST-segment resolution and late (6-month) left ventricular remodeling after acute myocardial infarction. | Q44314856 | ||
| B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction | Q44456354 | ||
| Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. | Q51835361 | ||
| Comparison of Different Bone Marrow-Derived Stem Cell Approaches in Reperfused STEMI. A Multicenter, Prospective, Randomized, Open-Labeled TECAM Trial. | Q53477149 | ||
| Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial | Q56610959 | ||
| Utilização de terapêuticas comprovadamente úteis no tratamento da coronariopatia aguda: comparação entre diferentes regiões brasileiras. Análise do Registro Brasileiro de Síndromes Coronarianas Agudas (BRACE - Brazilian Registry on Acute Cor | Q56786001 | ||
| Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Int | Q61942700 | ||
| ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators | Q73189810 | ||
| Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction | Q74302899 | ||
| P433 | issue | 3 | |
| P921 | main subject | ejection fraction | Q641303 |
| multicenter clinical trial | Q6934595 | ||
| P304 | page(s) | 392-399 | |
| P577 | publication date | 2018-03-22 | |
| P1433 | published in | Clinical Cardiology | Q4502312 |
| P1476 | title | Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial | |
| P478 | volume | 41 |
Search more.